A 2026 UK review of the ~one-third of UK adults with insomnia symptoms, the glymphatic waste-clearance and amyloid link, the synaptic homeostasis hypothesis, why CBT-i and daridorexant (NICE TA922) come first, the BDNF / HGF-c-Met case, the vivid-dreams mismatch and why fixing sleep, not a peptide, comes first Read the full review Occupational & Stress Neuroscience 17 June 2026 Dihexa for Burnout Brain Fog: Chronic Work Stress, Cortisol, Cognition & the 2026 UK Review Im so burned out I cant think straight. In 2024/25 the HSE recorded a record 964,000 UK workers with work-related stress, depression or anxiety 22.1 million working days lost and the Mental Health UK Burnout Report 2026 found 91% had faced high pressure in the past year
Vendor technical sheets and primary studies report selectivity over related methyltransferases and enzymes of the NAD salvage pathway [1,6,7]
In formal pharmacokinetic studies in rats following intravenous administration, BPC-157 has a mean elimination half-life of approximately 15.2 minutes, with the peptide becoming undetectable within 4 hours
BPC-157 and TB-500: Frequency and Timing BPC-157 is typically administered twice daily, morning and evening, to maintain consistent tissue-level concentrations throughout the day